Search

Author/Creator Buyse, M

1. Effects of neratinib on health-related quality of life in women with HER2-positive early-stage breast cancer: longitudinal analyses from the randomized phase III ExteNET trial. (23rd January 2019)

Authors:
Delaloge, S; Cella, D; Ye, Y; Buyse, M; Chan, A; Barrios, C H; Holmes, F A; Mansi, J; Iwata, H; Ejlertsen, B; Moy, B; Chia, S K L; Gnant, M; Smichkoska, S; Ciceniene, A; Martinez, N; Filipović, S; Ben-Baruch, N E; Joy, A A; Langkjer, S T
Journal:
Annals of oncology
Issue:
Volume 30:Number 4(2019)
Page Start:
567
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Palbociclib as single agent or in combination with the endocrine therapy received before disease progression for estrogen receptor-positive, HER2-negative metastatic breast cancer: TREnd trial. (11th June 2018)

Authors:
Malorni, L; Curigliano, G; Minisini, A M; Cinieri, S; Tondini, C A; D'Hollander, K; Arpino, G; Bernardo, A; Martignetti, A; Criscitiello, C; Puglisi, F; Pestrin, M; Sanna, G; Moretti, E; Risi, E; Biagioni, C; McCartney, A; Boni, L; Buyse, M; Migliaccio, I
Journal:
Annals of oncology
Issue:
Volume 29:Number 8(2018)
Page Start:
1748
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. The hard road to data interpretation: 3 or 6 months of adjuvant chemotherapy for patients with stage III colon cancer?. (9th February 2018)

Authors:
Sobrero, A; Grothey, A; Iveson, T; Labianca, R; Yoshino, T; Taieb, J; Maughan, T; Buyse, M; André, T; Meyerhardt, J; Shields, A F; Souglakos, I; Douillard, J -Y; Cervantes, A
Journal:
Annals of oncology
Issue:
Volume 29:Number 5(2018)
Page Start:
1099
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗